The Israeli company has developed an electrical stimulation patch for treating premature ejaculation, which is operated by a smartphone app.
The company has announced a six-month agreement with "a leading medical instruments company" to develop a prototype biological implant.
As Teva's share price plunges to a 15-year low, Leader Capital Markets analyst Sabina Levy provides some perspective.
The Tel Aviv based company's dry eye treatment is preparing for a Phase IIa trial, having shown efficacy in an initial clinical proof of concept study.
It was announced last month that Schlaff's company would invest $5 million in CollPlant, propelling the company's market cap up to NIS 85 million.
The increase is likely to be particularly steep for older people.
The spinal surgery systems company posted a record $17 million in revenue.
The new center will be located in Haifa Economic Corporation's life sciences park.
The shares have nevertheless not made up the ground lost in the two years during which they were listed on the TASE.
Targeted flavor delivery developer DouxMatok recently raised $8.1 million from Pitango.
Copaxone co-inventor Prof. Michael Sela talks to 'Globes" about what makes it a special drug.
"The moment Teva's debt falls below $30 billion the situation will be different," says the Teva shareholder and former senior executive and director.
Following successful trials with rabbits, the Ra'anana based company is moving toward first implantation in humans by mid-2018.
Dr Ehud Marom, former head of Teva's Copaxone business: It's a pity that Teva took all the profit from Copaxone and invested it in Allergan.
More energetic than ever, Arie Belldegrun talks to "Globes" about Kite Pharma's remarkable journey and the future of cancer treatment.
Accelmed seeks to replicate its success formula in urology, as portfolio company Cogentix makes a third acquisition.
Israeli company Essence develops products that enable people to keep living at home in old age.
The Weizmann Institute researcher's groundbreaking research on Alzheimer's Disease is leading to new treatment for it.